Drug Utilization / Health Services Research

((SLB-027)) (SLB-027) Association between traumatic brain injury and post-hospitalization opioid dose among prevalent opioid users

((SLB-028)) (SLB-028) Utilization of Statins and other Lipid-Modifying Agents During Pregnancy in the US, 2005-2021

((SLB-029)) (SLB-029) Early Identification of Prodromal Symptoms for Multiple Sclerosis Risk Prediction Using Machine Learning Approaches

((SLB-030)) (SLB-030) Risk of Acute Kidney Injury with Non-vitamin K Antagonist Oral Anticoagulants Use: A Retrospective Cohort Study

((SLB-031)) (SLB-031) Disparities in the Utilization of Nirmatrelvir-Ritonavir in Taiwan: An Analysis Within a Universal Healthcare System During the COVID-19 Pandemic

((SLB-032)) (SLB-032) Adverse Outcomes Associated with High-Risk Medication Administered to Children during the Dental Visit, 2014-2020

((SLB-033)) (SLB-033) A drug utilization study of Z-drug within psychiatric outpatients in regional hospital during the era of post-pandemic

((SLB-034)) (SLB-034) Treatment Patterns in Pediatrics with Attention-Deficit Hyperactivity Disorder (ADHD) in Taiwan

((SLB-035)) (SLB-035) Real-World Use of Accelerated Approval Oncology Drugs That Are Subsequently Withdrawn in the United States

((B-044)) (B-044) Buprenorphine and Methadone Initiation Among People with HIV and Diagnosed Opioid Use Disorder in a Clinical Cohort in Baltimore, Maryland

((B-045)) (B-045) Uptake and use of biologic medicines in paediatric immune-mediated inflammatory diseases: An Australian population-based study